Get the Stockscreener App
6.11
6.26%
0.36
After Hours:
6.09
-0.02
-0.33%
Avita Medical Inc stock is traded at $6.11, with a volume of 274.31K.
It is up +6.26% in the last 24 hours and down -33.66% over the past month.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$5.75
Open:
$5.85
24h Volume:
274.31K
Relative Volume:
1.09
Market Cap:
$148.56M
Revenue:
$50.14M
Net Income/Loss:
$-35.38M
P/E Ratio:
-4.3643
EPS:
-1.4
Net Cash Flow:
$-39.46M
1W Performance:
+8.72%
1M Performance:
-33.66%
6M Performance:
-53.29%
1Y Performance:
-36.15%
1-Day Range:
$5.75
$6.33
1-Week Range:
$5.565
$6.33
52-Week Range:
$5.46
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
6.11 | 148.56M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
AVITA Medical (NASDAQ:RCEL) Given Buy Rating at D. Boral Capital - MarketBeat
RCEL: AVITA Medical Maintains Buy Rating with $19 Price Target | RCEL Stock News - GuruFocus
AVITA Medical, Inc. (NASDAQ:RCEL) Short Interest Up 23.9% in May - MarketBeat
Avita Medical (RCEL) Unveils Promising Results for Cohealyx in Wound Treatment | RCEL Stock News - GuruFocus
AVITA Medical’s Cohealyx shows promise in wound care - Investing.com
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ | RCEL Stock News - GuruFocus
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ - The Manila Times
AVITA Medical’s Cohealyx shows promise in wound care By Investing.com - Investing.com UK
Avita Medical Stockholders Approve Key Amendments and Elections - TipRanks
Transcript : AVITA Medical, Inc.Shareholder/Analyst Call - marketscreener.com
(RCEL) Investment Report - news.stocktradersdaily.com
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards - Yahoo Finance
AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards | RCEL Stock News - GuruFocus
No normal is the new normal - The Globe and Mail
Revolutionary Wound Care Tech RECELL Crowned Best Surgical Innovation: How 30,000 Patients Benefited - Stock Titan
Stocks in play: Fury Gold Mines Limited - The Globe and Mail
Translational Regenerative Medicine Market Is Booming So Rapidly | Athersys, Avita Medical, AxoGen - openPR.com
Deutsche Bank AG Has $292,000 Holdings in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical stock hits 52-week low at $5.54 amid market challenges - Investing.com Canada
Is Abercrombie & Fitch Stock a Buy in June 2025? - The Globe and Mail
Shareholders Will Probably Not Have Any Issues With AVITA Medical, Inc.'s (NASDAQ:RCEL) CEO Compensation - simplywall.st
Is Amazon Stock Ready for a Significant Rebound? - The Globe and Mail
Jane Street Group LLC Sells 36,440 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Delta Investment Management LLC Buys 38,042 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - MarketBeat
(RCEL) Trading Signals - news.stocktradersdaily.com
Northern Trust Corp Raises Stock Holdings in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Will AVITA's Burn Care Breakthroughs Deliver A Healing Touch For Investors? - RTTNews
Navitas Semiconductor Just Landed a Nvidia Deal. How Should You Play NVTS Stock Here? - The Globe and Mail
FY2025 EPS Estimates for AVITA Medical Boosted by Analyst - MarketBeat
Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher - MSN
Price T Rowe Associates Inc. MD Sells 9,796 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical Updates Bylaws for Governance Enhancement - TipRanks
Cantor Fitzgerald Comments on AVITA Medical FY2025 Earnings - Defense World
(RCEL) Technical Data - news.stocktradersdaily.com
AVITA downgraded by Piper Sandler over sales outlook - MSN
AVITA Medical's Acute Wound Care Showcase 2025 Streams Live Today - The Manila Times
AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today - Yahoo Finance
AVITA Medical: Near Perfect Execution Needed To Navigate Through Balance Sheet Challenges - Seeking Alpha
Why AVITA, Botanix, Brainchip, and NAB shares are falling today - The Motley Fool Australia
Analysts Have Been Trimming Their AVITA Medical, Inc. (NASDAQ:RCEL) Price Target After Its Latest Report - Yahoo Finance
Contrasting GBS (NYSE:GBS) and AVITA Medical (NASDAQ:RCEL) - Defense World
Wells Fargo & Company MN Boosts Stock Position in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AVITA Medical, Inc. (NASDAQ:RCEL) Q1 2025 Earnings Call Transcript - Insider Monkey
Cantor maintains Avita Medical stock Overweight, $19 target post-Q1 By Investing.com - Investing.com Canada
AVITA Medical outlines $3.5B US market opportunity with expanded product portfolio and 2025 revenue guidance - MSN
Avita Medical (RCEL) Target Price Adjusted by TD Cowen | RCEL St - GuruFocus
Avita Medical Shares Decline on 1Q Revenue Miss - MarketWatch
Barclays PLC Purchases 3,526 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita’s Road to Profitability Is in Sight - Morningstar
AVITA Medical (RCEL) Sees Revenue Surge with Product Launches - GuruFocus
AVITA Medical Inc (AVHHL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.56%
1.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):